GLP1

Obesity significantly increases the risk of severe infection, hospitalisation, and mortality, not just long-term chronic disease

It was a great pleasure to be asked to go back to Liverpool John Moores University to present to final year pharmacy students about weight loss. I would like at some point to do this on a more regular basis.  And what an exciting time to present on this topic. There are so many things […]

GLP-1 receptor agonists are not just making waves in weight management and diabetes care—they’re showing potential in addressing various forms of addiction. By modulating dopamine pathways in the brain, these medications could help reduce cravings and compulsive behaviours across a spectrum of addictions.

When comparing the viral TikTok trends “Oatzempic” and “Ricezempic,” both draw inspiration from the popular weight-loss drug Ozempic but are quite different in their composition and effects.  Oatzempic uses oats, particularly focusing on high-fiber varieties like steel-cut or rolled oats, which are more nutrient-dense compared to instant oats. These oats contain soluble fiber, especially beta-glucan, […]

There are no direct head-to-head trials between semaglutide (Wegovy) and tirzepatide (Mounjaro). So, what we have to date is like comparing two world-class boxers and asking who is the best, when they have never actually fought each other. This study uses statistical analysis to virtually “match” and “pair-up” participants in different trials to provide a better comparison of the effectiveness of the two drugs.

Understanding Obstructive Sleep Apnoea (OSA) Obstructive Sleep Apnoea (OSA) is a common sleep disorder where your airway repeatedly gets blocked during sleep, leading to interrupted breathing. This can cause loud snoring, choking or gasping for air, and excessive daytime sleepiness. Untreated OSA can lead to serious health issues like heart disease and stroke. How is […]

The SELECT trial has provided significant insights into the cardiovascular benefits of semaglutide, a GLP-1 receptor agonist, for individuals who are obese or overweight and do not have diabetes. This study aimed to determine whether semaglutide could reduce the incidence of major adverse cardiovascular events (MACE) in this population. Here’s a concise overview of the […]

Wegogy and Ozempic are in short supply. This has prompted a rise in fake products that have the potential to kill.

How to boost your clinic income. Medical Weight Loss is a great way to improve clinic income and to also add a more medical emphasis to your aesthetic clinic.

Welcome, finally to Wegovy, the weight loss licensed version of Ozempic to the UK. The clinical trials have shown never before seen results with this medication.